[
  {
    "ts": "2025-10-01T22:00:03+00:00",
    "headline": "Boston Scientific (BSX) Stock Dips While Market Gains: Key Facts",
    "summary": "The latest trading day saw Boston Scientific (BSX) settling at $95.85, representing a -1.82% change from its previous close.",
    "url": "https://finance.yahoo.com/news/boston-scientific-bsx-stock-dips-220003809.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "7c062651-2bd1-3be7-99b8-c6539b34951a",
      "content": {
        "id": "7c062651-2bd1-3be7-99b8-c6539b34951a",
        "contentType": "STORY",
        "title": "Boston Scientific (BSX) Stock Dips While Market Gains: Key Facts",
        "description": "",
        "summary": "The latest trading day saw Boston Scientific (BSX) settling at $95.85, representing a -1.82% change from its previous close.",
        "pubDate": "2025-10-01T22:00:03Z",
        "displayTime": "2025-10-01T22:00:03Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/bdc2850a48a0f40806db817a9e24f36f",
          "originalWidth": 900,
          "originalHeight": 601,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EmhBrL1RMEs5kGBSUQzx5g--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/bdc2850a48a0f40806db817a9e24f36f.cf.webp",
              "width": 900,
              "height": 601,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CMWRvhn58nUVOwpQjtvr2Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/bdc2850a48a0f40806db817a9e24f36f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-bsx-stock-dips-220003809.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-bsx-stock-dips-220003809.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-01T13:10:00+00:00",
    "headline": "Hologic Bets on Endomagnetics to Fuel Interventional Breast Momentum",
    "summary": "HOLX's Interventional Breast business hits $100M as Endomag products boost recurring revenues and margins.",
    "url": "https://finance.yahoo.com/news/hologic-bets-endomagnetics-fuel-interventional-131000801.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "b3c255a2-232b-3056-946a-98c5f3455efe",
      "content": {
        "id": "b3c255a2-232b-3056-946a-98c5f3455efe",
        "contentType": "STORY",
        "title": "Hologic Bets on Endomagnetics to Fuel Interventional Breast Momentum",
        "description": "",
        "summary": "HOLX's Interventional Breast business hits $100M as Endomag products boost recurring revenues and margins.",
        "pubDate": "2025-10-01T13:10:00Z",
        "displayTime": "2025-10-01T13:10:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TNBAnrhWOnvvvNSvMEIuFg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rP7ZEHNft_Sb_FB9M.3i3w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/hologic-bets-endomagnetics-fuel-interventional-131000801.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/hologic-bets-endomagnetics-fuel-interventional-131000801.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            },
            {
              "symbol": "SYK"
            },
            {
              "symbol": "HOLX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-01T12:41:00+00:00",
    "headline": "Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million",
    "summary": "- Strengthened balance sheet to fully fund development and launch of NXT-41 platform - - Biologics for breast reconstruction represents $1.5 billion U.S. total addressable market - GAITHERSBURG, Md., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced the closing of the sale of its BioEnvelope business, including the EluPro™ and CanGaroo® bioenvelopes, to Boston Scientific Corporation (NYSE: B",
    "url": "https://finance.yahoo.com/news/elutia-announces-closing-bioenvelope-business-124100959.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "c0452643-26f8-336a-b1de-58765dfeb89a",
      "content": {
        "id": "c0452643-26f8-336a-b1de-58765dfeb89a",
        "contentType": "STORY",
        "title": "Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million",
        "description": "",
        "summary": "- Strengthened balance sheet to fully fund development and launch of NXT-41 platform - - Biologics for breast reconstruction represents $1.5 billion U.S. total addressable market - GAITHERSBURG, Md., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced the closing of the sale of its BioEnvelope business, including the EluPro™ and CanGaroo® bioenvelopes, to Boston Scientific Corporation (NYSE: B",
        "pubDate": "2025-10-01T12:41:00Z",
        "displayTime": "2025-10-01T12:41:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/acb8ce730ecd9f3870468a11e1c1300d",
          "originalWidth": 2048,
          "originalHeight": 455,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UZDWpsnvZMiblfXugK_fkw--~B/aD00NTU7dz0yMDQ4O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/acb8ce730ecd9f3870468a11e1c1300d.cf.webp",
              "width": 2048,
              "height": 455,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vHtfmG3ERYsDP0feqscEWg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/acb8ce730ecd9f3870468a11e1c1300d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/elutia-announces-closing-bioenvelope-business-124100959.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/elutia-announces-closing-bioenvelope-business-124100959.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ELUT"
            },
            {
              "symbol": "BSX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-01T10:55:37+00:00",
    "headline": "Boston Scientific unveils plans for new Watchman device",
    "summary": "The company hopes to launch its next-generation Watchman system in the second half of 2027 or early 2028.",
    "url": "https://www.medtechdive.com/news/boston-scientific-unveils-new-watchman-device/761592/",
    "source": "MedTech Dive",
    "provider": "yfinance",
    "raw": {
      "id": "12421bf2-fdcd-388e-92d3-0e2780669312",
      "content": {
        "id": "12421bf2-fdcd-388e-92d3-0e2780669312",
        "contentType": "STORY",
        "title": "Boston Scientific unveils plans for new Watchman device",
        "description": "",
        "summary": "The company hopes to launch its next-generation Watchman system in the second half of 2027 or early 2028.",
        "pubDate": "2025-10-01T10:55:37Z",
        "displayTime": "2025-10-01T10:55:37Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/medtech_dive_335/3039ae63e8502d47ba212b70eb72c32f",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "Boston Scientific’s Watchman FLX Pro device, the latest version of its left atrial appendage closure system, was approved by the FDA in 2023",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5fLXswk25c5IaUmfXQ40hw--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/medtech_dive_335/3039ae63e8502d47ba212b70eb72c32f.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yNVLYGze33w3oJyVI_i._g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/medtech_dive_335/3039ae63e8502d47ba212b70eb72c32f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MedTech Dive",
          "url": "https://medtechdive.com/"
        },
        "canonicalUrl": {
          "url": "https://www.medtechdive.com/news/boston-scientific-unveils-new-watchman-device/761592/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-unveils-plans-watchman-105537101.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]